Revisiting prophylaxis of homeopathic interventions in COVID-19
Int. j. high dilution res
;
20(4): 2-5, Dec. 31, 2021.
Artigo
em Inglês
| LILACS, HomeoIndex
| ID: biblio-1396369
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by novel beta-coronavirus has emerged as a cause of coronavirus pandemic (COVID-19) declared by Public Health Emergency of International Concern (PHEIC). Korean oriental medicine, Traditional Chinese Medicine (TCM), and Indian systems of medicine known as AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Sowa-Rigpa and Homeopathy) had implemented various prophylactic measures and interim treatment guidelines in prevention and treatment for COVID -19 cases. However, even though different approaches were implemented to break the epidemic chain, we have not reached herd effect or herd immunity in the Indian population. Therefore, in this ongoing COVID-19 pandemic, a specific study on immune markers of IL-6 (Interleukin-6), D-Dimer, Ferritine, CRP (C-reactive protein) with SARS CoV-2 specific IgG & IgM antibodies need to be investigated for generating hard-core evidence for homeoprophylaxis in terms of immunity response. Therefore, there seems to be a need to revisit the program of homeoprophylaxis in the COVID -19 pandemic.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Imunoglobulinas
/
COVID-19
Tipo de estudo:
Guia de Prática Clínica
Idioma:
Inglês
Revista:
Int. j. high dilution res
Assunto da revista:
Homeopatia
/
Terapias Complementares
Ano de publicação:
2021
Tipo de documento:
Artigo
País de afiliação:
Índia
Instituição/País de afiliação:
Dr. D. Y. Patil Homoeopathic Medical College and Research Centre/IN
Similares
MEDLINE
...
LILACS
LIS